96 related articles for article (PubMed ID: 20633634)
1. Physio-pathological parameters affect the activation of inflammatory pathways by deoxynivalenol in Caco-2 cells.
Van De Walle J; During A; Piront N; Toussaint O; Schneider YJ; Larondelle Y
Toxicol In Vitro; 2010 Oct; 24(7):1890-8. PubMed ID: 20633634
[TBL] [Abstract][Full Text] [Related]
2. Influence of deoxynivalenol on NF-kappaB activation and IL-8 secretion in human intestinal Caco-2 cells.
Van De Walle J; Romier B; Larondelle Y; Schneider YJ
Toxicol Lett; 2008 Apr; 177(3):205-14. PubMed ID: 18343055
[TBL] [Abstract][Full Text] [Related]
3. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis.
De Walle JV; Sergent T; Piront N; Toussaint O; Schneider YJ; Larondelle Y
Toxicol Appl Pharmacol; 2010 Jun; 245(3):291-8. PubMed ID: 20362602
[TBL] [Abstract][Full Text] [Related]
4. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria.
Maresca M; Yahi N; Younès-Sakr L; Boyron M; Caporiccio B; Fantini J
Toxicol Appl Pharmacol; 2008 Apr; 228(1):84-92. PubMed ID: 18308354
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation.
Van De Walle J; Hendrickx A; Romier B; Larondelle Y; Schneider YJ
Toxicol In Vitro; 2010 Aug; 24(5):1441-9. PubMed ID: 20406675
[TBL] [Abstract][Full Text] [Related]
6. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations.
Sergent T; Parys M; Garsou S; Pussemier L; Schneider YJ; Larondelle Y
Toxicol Lett; 2006 Jul; 164(2):167-76. PubMed ID: 16442754
[TBL] [Abstract][Full Text] [Related]
7. Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2.
Diesing AK; Nossol C; Panther P; Walk N; Post A; Kluess J; Kreutzmann P; Dänicke S; Rothkötter HJ; Kahlert S
Toxicol Lett; 2011 Jan; 200(1-2):8-18. PubMed ID: 20937367
[TBL] [Abstract][Full Text] [Related]
8. Cadmium-induced hormetic effect in differentiated Caco-2 cells: ERK and p38 activation without cell proliferation stimulation.
Mantha M; Jumarie C
J Cell Physiol; 2010 Jul; 224(1):250-61. PubMed ID: 20232314
[TBL] [Abstract][Full Text] [Related]
9. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression.
Pinton P; Nougayrède JP; Del Rio JC; Moreno C; Marin DE; Ferrier L; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Appl Pharmacol; 2009 May; 237(1):41-8. PubMed ID: 19289138
[TBL] [Abstract][Full Text] [Related]
10. Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay.
Bony S; Carcelen M; Olivier L; Devaux A
Toxicol Lett; 2006 Sep; 166(1):67-76. PubMed ID: 16828243
[TBL] [Abstract][Full Text] [Related]
11. Deoxynivalenol (DON) is toxic to human colonic, lung and monocytic cell lines, but does not increase the IgE response in a mouse model for allergy.
Instanes C; Hetland G
Toxicology; 2004 Nov; 204(1):13-21. PubMed ID: 15369845
[TBL] [Abstract][Full Text] [Related]
12. The Food-Associated Ribotoxin Deoxynivalenol Modulates Inducible NO Synthase in Human Intestinal Cell Model.
Graziani F; Pujol A; Nicoletti C; Pinton P; Armand L; Di Pasquale E; Oswald IP; Perrier J; Maresca M
Toxicol Sci; 2015 Jun; 145(2):372-82. PubMed ID: 25766886
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases.
Pinton P; Tsybulskyy D; Lucioli J; Laffitte J; Callu P; Lyazhri F; Grosjean F; Bracarense AP; Kolf-Clauw M; Oswald IP
Toxicol Sci; 2012 Nov; 130(1):180-90. PubMed ID: 22859312
[TBL] [Abstract][Full Text] [Related]
14. Dual effects exerted in vitro by micromolar concentrations of deoxynivalenol on undifferentiated caco-2 cells.
Manda G; Mocanu MA; Marin DE; Taranu I
Toxins (Basel); 2015 Feb; 7(2):593-603. PubMed ID: 25690693
[TBL] [Abstract][Full Text] [Related]
15. The effects of deoxynivalenol on gene expression in the murine thymus.
van Kol SW; Hendriksen PJ; van Loveren H; Peijnenburg A
Toxicol Appl Pharmacol; 2011 Feb; 250(3):299-311. PubMed ID: 21074547
[TBL] [Abstract][Full Text] [Related]
16. Cadmium induces interleukin-8 production via NF-kappaB activation in the human intestinal epithelial cell, Caco-2.
Hyun JS; Satsu H; Shimizu M
Cytokine; 2007 Jan; 37(1):26-34. PubMed ID: 17391980
[TBL] [Abstract][Full Text] [Related]
17. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol.
Choi HJ; Yang H; Park SH; Moon Y
Toxicol Appl Pharmacol; 2009 Oct; 240(1):46-54. PubMed ID: 19591856
[TBL] [Abstract][Full Text] [Related]
18. Deoxynivalenol induced mouse skin cell proliferation and inflammation via MAPK pathway.
Mishra S; Tripathi A; Chaudhari BP; Dwivedi PD; Pandey HP; Das M
Toxicol Appl Pharmacol; 2014 Sep; 279(2):186-97. PubMed ID: 24937323
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of deoxynivalenol-induced IL-8 expression in human monocytes.
Gray JS; Pestka JJ
Toxicol Sci; 2007 Oct; 99(2):502-11. PubMed ID: 17636245
[TBL] [Abstract][Full Text] [Related]
20. New insights into mycotoxin mixtures: the toxicity of low doses of Type B trichothecenes on intestinal epithelial cells is synergistic.
Alassane-Kpembi I; Kolf-Clauw M; Gauthier T; Abrami R; Abiola FA; Oswald IP; Puel O
Toxicol Appl Pharmacol; 2013 Oct; 272(1):191-8. PubMed ID: 23735874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
